Eastern Europe: Market for Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives 2024

Market Size for Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives in Eastern Europe

In 2023, the East European market for medicaments of antibiotics other than penicillins, streptomycins or their derivatives decreased by X% to $X, falling for the sixth consecutive year after two years of growth. In general, consumption, however, continues to indicate a deep slump. Over the period under review, the market hit record highs at $X in 2012; however, from 2013 to 2023, consumption failed to regain momentum.

Production of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives in Eastern Europe

In value terms, non-penicillin or streptomycin antibiotic medicaments production declined slightly to $X in 2023 estimated in export price. In general, production, however, showed a noticeable slump. The most prominent rate of growth was recorded in 2017 when the production volume increased by X%. Over the period under review, production hit record highs at $X in 2012; however, from 2013 to 2023, production stood at a somewhat lower figure.

Exports of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives

Exports in Eastern Europe

In 2023, shipments abroad of medicaments of antibiotics other than penicillins, streptomycins or their derivatives was finally on the rise to reach X tons for the first time since 2020, thus ending a two-year declining trend. Over the period under review, exports recorded buoyant growth. The pace of growth was the most pronounced in 2015 when exports increased by X% against the previous year. The volume of export peaked at X tons in 2020; however, from 2021 to 2023, the exports stood at a somewhat lower figure.

In value terms, non-penicillin or streptomycin antibiotic medicaments exports skyrocketed to $X in 2023. Total exports indicated a buoyant increase from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

Exports by Country

In 2023, Bulgaria (X tons), distantly followed by Poland (X tons), Russia (X tons), Belarus (X tons), Romania (X tons), Estonia (X tons), Hungary (X tons) and Ukraine (X tons) were the main exporters of medicaments of antibiotics other than penicillins, streptomycins or their derivatives, together creating X% of total exports.

From 2012 to 2023, the biggest increases were recorded for Bulgaria (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the largest non-penicillin or streptomycin antibiotic medicaments supplying countries in Eastern Europe were Bulgaria ($X), Poland ($X) and Romania ($X), with a combined X% share of total exports.

In terms of the main exporting countries, Bulgaria, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2023, the export price in Eastern Europe amounted to $X per ton, almost unchanged from the previous year. Over the period under review, the export price saw a perceptible descent. The most prominent rate of growth was recorded in 2022 when the export price increased by X%. The level of export peaked at $X per ton in 2012; however, from 2013 to 2023, the export prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Hungary ($X per ton), while Estonia ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Bulgaria (X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives

Imports in Eastern Europe

In 2023, supplies from abroad of medicaments of antibiotics other than penicillins, streptomycins or their derivatives increased by X% to X tons for the first time since 2020, thus ending a two-year declining trend. The total import volume increased at an average annual rate of X% from 2012 to 2023; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2019 when imports increased by X% against the previous year. Over the period under review, imports attained the maximum at X tons in 2020; however, from 2021 to 2023, imports remained at a lower figure.

In value terms, non-penicillin or streptomycin antibiotic medicaments imports stood at $X in 2023. Overall, imports, however, saw a perceptible slump. The pace of growth was the most pronounced in 2019 with an increase of X% against the previous year. The level of import peaked at $X in 2012; however, from 2013 to 2023, imports failed to regain momentum.

Imports by Country

In 2023, Russia (X tons) was the largest importer of medicaments of antibiotics other than penicillins, streptomycins or their derivatives, making up X% of total imports. It was distantly followed by Poland (X tons), Romania (X tons), Ukraine (X tons) and Belarus (X tons), together mixing up a X% share of total imports. The following importers - the Czech Republic (X tons) and Bulgaria (X tons) - each finished at an X% share of total imports.

Russia experienced a relatively flat trend pattern with regard to volume of imports of medicaments of antibiotics other than penicillins, streptomycins or their derivatives. At the same time, Bulgaria (X%), Poland (X%), the Czech Republic (X%), Romania (X%) and Belarus (X%) displayed positive paces of growth. Moreover, Bulgaria emerged as the fastest-growing importer imported in Eastern Europe, with a CAGR of X% from 2012-2023. By contrast, Ukraine (X%) illustrated a downward trend over the same period. While the share of Poland (X p.p.) and Romania (X p.p.) increased significantly in terms of the total imports from 2012-2023, the share of Russia (X p.p.) and Ukraine (X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest non-penicillin or streptomycin antibiotic medicaments importing markets in Eastern Europe were Russia ($X), Poland ($X) and Romania ($X), together accounting for X% of total imports.

Poland, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2023, the import price in Eastern Europe amounted to $X per ton, waning by X% against the previous year. Overall, the import price continues to indicate a noticeable reduction. The growth pace was the most rapid in 2022 an increase of X% against the previous year. The level of import peaked at $X per ton in 2012; however, from 2013 to 2023, import prices failed to regain momentum.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was the Czech Republic ($X per ton), while Belarus ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Poland (X%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Platform